Skip to main content
RCT
NASDAQ Trade & Services

Shareholders Approve Massive Share Authorization and Waive Pre-emption Rights, Enabling Significant Future Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Negative
Importance info
8
Price
$0.643
Mkt Cap
$27.863M
52W Low
$0.621
52W High
$5.36
52W Position info
3.5% above low
Off High info
88% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

RCT is trading near its 52-week low of $0.621 (3.5% above the low).

Summary

RedCloud Holdings plc shareholders approved the authorization for the board to issue up to 1 billion new shares and waived pre-emption rights, setting the stage for substantial potential dilution.


Key Events · Financing and Capital Events · RCT

  • Massive Share Allotment Authority Granted

    Shareholders authorized the board to generally and unconditionally allot up to 1,000,000,000 new ordinary shares. With 55,606,812 shares currently outstanding, if all authorized shares were issued, dilution would be approximately 1798%.

  • Pre-emption Rights Disapplied

    The board was empowered to allot equity securities wholly for cash without being subject to pre-emption rights, removing a protective mechanism for existing shareholders against dilution.

  • Board Size Increased

    The maximum number of directors on the Board of Directors was increased to eleven.


Analysis · RCT · Trade & Services

RedCloud Holdings plc shareholders have granted the board authority to issue up to 1 billion new ordinary shares, a staggering amount compared to the current 55.6 million shares outstanding. This authorization, coupled with the disapplication of pre-emption rights, allows the company to raise substantial capital through equity offerings without first offering shares to existing shareholders. This move creates a significant overhang on the stock and signals the potential for extreme dilution, especially concerning as the company's stock is currently trading near its 52-week low. Investors should be aware of the substantial dilution risk this authorization represents.

At the time of this filing, RCT was trading at $0.64 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $27.9M. The 52-week trading range was $0.62 to $5.36. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RCT - Latest Insights

RCT
Jul 21, 2026, 5:28 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $0.2352
Real-time Price: $0.1925 info
Change: -$0.0427 (-18%) info
Market Cap: $13.355M info
RCT
Jul 15, 2026, 4:37 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.251
Real-time Price: $0.1925 info
Change: -$0.0585 (-23%) info
Market Cap: $13.355M info
RCT
Jul 06, 2026, 9:27 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.2447
Real-time Price: $0.1925 info
Change: -$0.0522 (-21%) info
Market Cap: $13.355M info
RCT
Jun 25, 2026, 5:07 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.3048
Real-time Price: $0.1925 info
Change: -$0.1123 (-37%) info
Market Cap: $13.355M info
RCT
Jun 24, 2026, 9:20 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.6293
Real-time Price: $0.1925 info
Change: -$0.4368 (-69%) info
Market Cap: $13.355M info